Faster Than The Speed Of Guidance: FDA Explores New Ways To Issue Updates
This article was originally published in The Gray Sheet
Executive Summary
FDA is exploring ways to inform industry of changes to its regulatory expectations more quickly than guidance documents or standards development allow, device center director Jeffrey Shuren said last week
You may also be interested in...
Former 510(k) Staff Director Takes Critical Look At FDA's Reform Plan
As FDA rolls out changes to its 510(k) review process, Heather Rosecrans, former director of the 510(k) program staff, and now on the industry side of the debate, is watching with keen interest and some trepidation.
Former 510(k) Staff Director Takes Critical Look At FDA's Reform Plan
As FDA rolls out changes to its 510(k) review process, Heather Rosecrans, former director of the 510(k) program staff, and now on the industry side of the debate, is watching with keen interest and some trepidation.
Industry Reps Meet With FDA Leadership To Talk Transparency
FDA is too slow to provide necessary information to companies, whether through guidance or responses to industry inquiries, medical device reps said during a recent listening session with the agency's Transparency Task Force